|国家科技期刊平台
首页|期刊导航|中国医学创新|肝切除术与经导管动脉栓塞化疗术治疗原发性肝癌破裂出血的临床效果比较

肝切除术与经导管动脉栓塞化疗术治疗原发性肝癌破裂出血的临床效果比较OA

Comparison of Clinical Effects between Hepatectomy and Transcatheter Arterial Chemoembolization in the Treatment of Primary Liver Cancer Rupture and Bleeding

中文摘要英文摘要

目的:比较肝切除术与经导管动脉栓塞化疗术(TACE)治疗原发性肝癌(PLC)破裂出血的临床效果.方法:选取 2018 年 10 月—2023 年 10 月滕州市中心人民医院收治的PLC破裂出血患者共计 80 例,按照治疗方法的不同分成TACE组(n=48)和肝切除术组(n=32).TACE组实施TACE治疗,肝切除术组实施肝切除术治疗.比较两组手术相关指标、肿瘤标志物水平、术后并发症、短期生存情况.结果:TACE组术中出血量、输血量均较肝切除术组更少,差异均有统计学意义(P<0.05).术后,两组血红蛋白(Hb)水平均较术前升高,总胆红素(TBIL)水平均较术前下降,TACE组Hb水平较肝切除术组更高,TBIL水平更低,差异均有统计学意义(P<0.05).术后,两组甲胎蛋白(AFP)、癌胚抗原(CEA)水平均较术前下降,差异均有统计学意义(P<0.05),TACE组水平与肝切除术组比较,差异均无统计学意义(P>0.05).TACE组术后并发症发生率(4.17%)较肝切除术组(21.88%)更低,差异有统计学意义(P<0.05).TACE组短期生存率(93.75%)与肝切除术组(87.50%)比较,差异无统计学意义(P>0.05).结论:PLC破裂出血患者采用TACE治疗与肝切除术均可改善患者肿瘤标志物,短期生存率均较高,但TACE的止血效果更好,术后并发症更少.

Objective:To compare the clinical efficacy of hepatectomy and transcatheter arterial chemoembolization(TACE)in the treatment of rupture and bleeding in primary liver cancer(PLC).Method:A total of 80 patients with PLC rupture and bleeding who were admitted in Tengzhou Central People's Hospital from October 2018 to October 2023 were selected and divided into TACE group(n=48)and hepatectomy group(n=32)by different treatment method.The TACE group received TACE treatment,while the hepatectomy group received hepatectomy treatment.The surgical related indicators,tumor marker level,postoperative complications,and short-term survival in both groups were compared.Result:The intraoperative bleeding volume and blood transfusion volume in the TACE group were less compared to those in hepatectomy group,the differences were statistically significant(P<0.05).After surgery,the hemoglobin(Hb)levels in both groups were increased compared to preoperative levels,and total bilirubin(TBIL)levels were decreased compared to preoperative levels,the Hb level of the TACE group was higher compared to that of hepatectomy group,and the TBIL level was lower,the differences were statistically significant(P<0.05).After surgery,the alpha fetoprotein(AFP),carcinoembryonic antigen(CEA)levels in both groups were decreased compared to preoperative levels,the differences were statistically significant(P<0.05),there were no statistically significant differences in the TACE group and the hepatectomy group(P>0.05).The incidence of postoperative complications in the TACE group(4.17%)was lower than that in the hepatectomy group(21.88%),the difference was statistically significant(P<0.05).There was no statistically significant difference in short-term survival rate between the TACE group(93.75%)and the hepatectomy group(87.50%)(P>0.05).Conclusion:Both TACE treatment and hepatectomy can improve tumor markers and have higher short-term survival rates in patients with PLC rupture and bleeding.However,TACE has a better hemostatic effect and fewer postoperative complications.

党同科;刘志超;张学江

滕州市中心人民医院肝胆外科 山东 滕州 277500滕州市中心人民医院血管外科 山东 滕州 277500

肝切除术经导管动脉栓塞化疗术原发性肝癌破裂出血

HepatectomyTranscatheter arterial chemoembolizationPrimary liver cancer rupture and bleeding

《中国医学创新》 2024 (024)

19-23 / 5

10.3969/j.issn.1674-4985.2024.24.005

评论